New Zealand vs Sur: New cases tested for RR-/MDR-TB
New Zealand
100.0%
in 2014
Sur
97.0%
in 2024
New Zealand rank
1st
Sur rank
2nd
New cases tested for RR-/MDR-TB over time
- New Zealand
- Sur
How they compare
New Zealand currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 2 times across 8 shared years of data; in 2005 it was New Zealand ahead.
New Zealand ranks 1st and Sur ranks 2nd of 192 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 32.2% | 67.8% | New Zealand |
| 2010s | 80.5% | 33.3% | 47.2% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, New Zealand or Sur?
- New Zealand, at 100.0% against 97.0% in Sur as of 2014.
- What is the difference in new cases tested for rr-/mdr-tb between New Zealand and Sur?
- 3.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Sur?
- 8 years are reported by both, from 2005 to 2014.
- How do New Zealand and Sur rank globally for new cases tested for rr-/mdr-tb?
- New Zealand ranks 1st and Sur ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.